TR200101109T2 - Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu - Google Patents

Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu

Info

Publication number
TR200101109T2
TR200101109T2 TR2001/01109T TR200101109T TR200101109T2 TR 200101109 T2 TR200101109 T2 TR 200101109T2 TR 2001/01109 T TR2001/01109 T TR 2001/01109T TR 200101109 T TR200101109 T TR 200101109T TR 200101109 T2 TR200101109 T2 TR 200101109T2
Authority
TR
Turkey
Prior art keywords
improved
vasodilating
efficacy
fluticasone
fluticasone lotion
Prior art date
Application number
TR2001/01109T
Other languages
English (en)
Inventor
J. Dow Gordon
Arthur Johnson Keith
Furr Kelly Frances
William Lathrop Robert
Rajagopalan Rukm�N�
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10841015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200101109(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200101109T2 publication Critical patent/TR200101109T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Bir flutikazon losyonu olup, gelistirilmis damar sikistiran ve iltihaplanma-önleyici tesirlilige ve beklenenden daha yüksek seviyedeki tesire sahip bulunmaktadir. flutikazon losyonu 0.05 agirlik yüzdesi flutikazon ptopiyonat ve ilaç katki maddelerini tasimakta olan bir su-içinde-yag araci ihtiva etmektedir.flutikazon losyonu gelistirilmis bir emniyetlilik profili sergilmekte iken beklenmedik bir sekilde istenen sonucu verebilme yetkinliginde olmaktadir.
TR2001/01109T 1998-10-22 1999-10-20 Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu TR200101109T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9823036.0A GB9823036D0 (en) 1998-10-22 1998-10-22 Fluticasone lotion having improved vasoconstrictor activity

Publications (1)

Publication Number Publication Date
TR200101109T2 true TR200101109T2 (tr) 2001-09-21

Family

ID=10841015

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01109T TR200101109T2 (tr) 1998-10-22 1999-10-20 Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu

Country Status (18)

Country Link
US (1) US7300669B2 (tr)
EP (1) EP1123101A1 (tr)
JP (1) JP2002528418A (tr)
KR (1) KR20010073220A (tr)
CN (1) CN1176659C (tr)
AU (1) AU754480B2 (tr)
BR (1) BR9914703A (tr)
CA (1) CA2347109A1 (tr)
CZ (1) CZ20011419A3 (tr)
GB (1) GB9823036D0 (tr)
HU (1) HUP0104251A2 (tr)
IL (1) IL142471A0 (tr)
NO (1) NO20011911D0 (tr)
NZ (1) NZ510949A (tr)
PL (1) PL348029A1 (tr)
TR (1) TR200101109T2 (tr)
WO (1) WO2000024401A1 (tr)
ZA (1) ZA200102971B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR032362A1 (es) * 2000-08-14 2003-11-05 Glaxo Group Ltd Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
US7897587B2 (en) 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
US20090233891A1 (en) * 2008-03-11 2009-09-17 Glenmark Generics Ltd. Pharmaceutical lotion comprising fluticasone propionate
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US20140371179A1 (en) * 2013-06-13 2014-12-18 Professional Compounding Centers Of America Methods and Compositions for Treating Esophageal Diseases
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
US10653656B2 (en) 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
GB9103764D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Compositions
WO1994014472A1 (en) * 1992-12-22 1994-07-07 The Regents Of The University Of California Method for inhibition of cell adhesion to receptors containing selectins

Also Published As

Publication number Publication date
CZ20011419A3 (cs) 2001-09-12
EP1123101A1 (en) 2001-08-16
HUP0104251A2 (hu) 2002-04-29
US20040176342A1 (en) 2004-09-09
NZ510949A (en) 2003-11-28
GB9823036D0 (en) 1998-12-16
NO20011911L (no) 2001-04-18
PL348029A1 (en) 2002-05-06
IL142471A0 (en) 2002-03-10
CN1326350A (zh) 2001-12-12
CA2347109A1 (en) 2000-05-04
AU754480B2 (en) 2002-11-14
WO2000024401A1 (en) 2000-05-04
US7300669B2 (en) 2007-11-27
BR9914703A (pt) 2001-07-10
KR20010073220A (ko) 2001-07-31
JP2002528418A (ja) 2002-09-03
CN1176659C (zh) 2004-11-24
NO20011911D0 (no) 2001-04-18
ZA200102971B (en) 2002-06-26
AU6352499A (en) 2000-05-15

Similar Documents

Publication Publication Date Title
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
FI980546A0 (fi) Koppling foer att reglera impedansen i en differential aktivkomponent
DE60002696D1 (de) Redundanzbeseitigung in der persistenz von objektgraphen
CA2288948A1 (en) Modified arginine deiminase
NL350077I1 (nl) Cyprosulfamide
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR9913087A (pt) Bateria enzimática
IT1285770B1 (it) Composti corticoidei
IT1303249B1 (it) Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
NO974375D0 (no) Stötfanger, samt tilvirkning av samme
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DE59407238D1 (de) Aktiver schalldämpfer
DE69839745D1 (de) Unterdrückung von Abschaltgeräuschen
DE69428407D1 (de) Rauscharmer bipolarer Transistor
BR9507203A (pt) Derivado de oxima e bactericida que contém o mesmo como ingredientes ativo
TR200101109T2 (tr) Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu
CY1106444T1 (el) 17b-νιτρο-11β-αρυλοστepοειδη και παραγωγα αυτων ως ορμονικοι αγωνιστες ή ανταγωνιστες
DE60027434D1 (de) Petroselinsäure enthaltendes hautpflegemittel
DE60039679D1 (de) Reduktion des molekulargewichts von olefincopolymerisaten
DE69616074D1 (de) Ara-c derivate
ES2186807T3 (es) Inhibidores de trombina.
FR2776671B1 (fr) Aciers faiblement allies anti-cokage
ATE305517T1 (de) Neurotrypsin
DE69318009D1 (de) Aktive rauschunterdrückung